Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 […]
Artisan Partners Limited Partnership increased its stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 24.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 100,235 shares of the company’s stock after purchasing an additional 19,819 shares during the period. […]
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price […]
Jump Financial LLC increased its position in Penumbra, Inc. (NYSE:PEN – Free Report) by 212.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,694 shares of the company’s stock after purchasing an additional 6,594 shares during the quarter. Jump Financial LLC’s holdings in Penumbra […]
Securian Asset Management Inc. trimmed its stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 5.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,255 shares of the company’s stock after selling 204 shares during the quarter. Securian Asset […]